US Bancorp DE reduced its holdings in Relx Plc (NYSE:RELX – Free Report) by 8.7% during the 4th quarter, Holdings Channel reports. The fund owned 175,510 shares of the technology company’s stock after selling 16,792 shares during the quarter. US Bancorp DE’s holdings in Relx were worth $7,094,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently added to or reduced their stakes in the business. Global Retirement Partners LLC increased its position in Relx by 6.3% in the 3rd quarter. Global Retirement Partners LLC now owns 4,067 shares of the technology company’s stock valued at $194,000 after acquiring an additional 240 shares during the period. Huntington National Bank lifted its stake in shares of Relx by 5.1% in the 3rd quarter. Huntington National Bank now owns 5,150 shares of the technology company’s stock worth $246,000 after acquiring an additional 250 shares during the period. Concurrent Investment Advisors LLC lifted its stake in shares of Relx by 3.2% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 8,039 shares of the technology company’s stock worth $384,000 after acquiring an additional 252 shares during the period. Bridgewater Advisors Inc. lifted its stake in shares of Relx by 2.5% in the 4th quarter. Bridgewater Advisors Inc. now owns 11,084 shares of the technology company’s stock worth $447,000 after acquiring an additional 267 shares during the period. Finally, Geneos Wealth Management Inc. lifted its stake in shares of Relx by 7.4% in the 2nd quarter. Geneos Wealth Management Inc. now owns 4,007 shares of the technology company’s stock worth $218,000 after acquiring an additional 275 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
RELX has been the subject of a number of research analyst reports. Zacks Research lowered shares of Relx from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 4th. Citigroup raised shares of Relx from a “neutral” rating to a “buy” rating in a research note on Wednesday, April 8th. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research note on Saturday, March 7th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research note on Monday, February 2nd. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy”.
Relx Price Performance
Shares of NYSE:RELX opened at $36.40 on Monday. Relx Plc has a twelve month low of $27.57 and a twelve month high of $56.33. The company has a 50 day moving average of $34.30 and a 200-day moving average of $37.92. The company has a quick ratio of 0.44, a current ratio of 0.49 and a debt-to-equity ratio of 2.38.
Relx (NYSE:RELX – Get Free Report) last released its earnings results on Wednesday, February 11th. The technology company reported $42.81 EPS for the quarter, beating the consensus estimate of $0.85 by $41.96. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $6.70 billion. On average, research analysts expect that Relx Plc will post 1.94 earnings per share for the current year.
Relx Announces Dividend
The firm also recently announced a dividend, which will be paid on Wednesday, June 24th. Investors of record on Friday, May 8th will be paid a dividend of $0.6559 per share. The ex-dividend date of this dividend is Friday, May 8th. This represents a yield of 422.0%.
Relx Company Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Featured Stories
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
